Back

Gut IgA Enhances Systemic IgG Responses to Pneumococcal Vaccines Through the Commensal Microbiota

Gutzeit, C.; Grasset, E. K.; Matthews, D. B.; Maglione, P. J.; Magri, G.; Britton, G. J.; Tomalin, L.; Pybus, M.; Tejedor Vaquero, S.; Veeramreddy, P. K.; Tacho-Pinot, R.; Martin Nalda, A.; Garcia Prat, M.; Martinez Gallo, M.; Dieli-Crimi, R.; Clemente, J. C.; Mehandru, S.; Suarez-Farina, M.; Faith, J. J.; Cunningham-Rundles, C.; Cerutti, A.

2021-04-30 immunology
10.1101/2021.04.29.439534 bioRxiv
Show abstract

The gut microbiota enhances systemic immunoglobulin G (IgG) responses to vaccines. However, it is unknown whether this effect involves IgA, a mucosal antibody that coats intestinal microbes. Here we found that gut IgA increased peripheral IgG responses to pneumococcal vaccines, as these responses were profoundly impaired in mice with global or mucosa-restricted IgA deficiency. The positive effect of IgA on vaccine-induced IgG production implicated gut bacteria. Indeed, IgG responses to pneumococcal vaccines were also defective in ex-germ free mice recolonized with gut microbes from mouse or human IgA-deficient donors. IgA exerted this IgG-enhancing effect by constraining the systemic translocation of intestinal commensal antigens, which caused chronic immune activation, including T cell overexpression of programmed death-1. This immune inhibitory receptor hindered vaccine-specific IgG production by eliciting functional B cell unresponsiveness, which was reverted by anti-programmed death-1 treatment. Thus, gut IgA is functionally interconnected with systemic IgG via intestinal microbes.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.